Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-P6 (Herzuma) vs Herceptin in Metastatic Breast Cancer
NCT01084863Phase 2Completed
- Sponsor
- Celltrion
- Start
- Feb 2010
- Primary completion
- Dec 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by Celltrion. Started Feb 2010; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01084863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01084863.